AIDS Drugs Help Cut Mass. Prison Deaths CDC Daily UpdateImportant note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




AIDS Drugs Help Cut Mass. Prison Deaths

Boston Globe (12/26/97) P. A1
Dowdy, Zachary R.


Abstract: Thanks to a Massachusetts state program that offers expensive medications and drug therapies to inmates with AIDS, the number of AIDS-related deaths in prison has fallen from 29 in 1990 to just one so far this year. According to the state Department of Public Health's (DPH's) medical provider, Correctional Medical Services, all inmates who would benefit from the program are eligible for access to combination drug therapies, including protease inhibitors. Alfred DeMaria, director of communicable disease control for DPH, notes that Massachusetts inmates have better access to the best drug therapies than some people in poorer, underinsured states. A number of state programs that fund AIDS treatments enable all Massachusetts residents who needs the drugs access to them. However, poor people in some other states are forced to go through a lottery system. Some critics argue that the prison drug program seems unfair. Says Miriam Shehane of Montgomery, Alabama's Victims of Crime and Leniency, "It does bother me that [the prisoners] are taken better care of than those of us outside of prison [in other states]." Meanwhile, doctors say inmates need top-quality health care, despite the cost and their crimes against society. Moreover, adds Anne De Groot of the Brown University School of Medicine, "Prisons are an exceptionally important point of entry for HIV-infected people to the health care system."


971229
AD972367


Copyright © 1997 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.